Steven Flostrand

Senior Director

Celgene

Steven has more than 20 years of commercial and consulting experience in the Life Science industry, including pricing, market access, marketing and sales positions. His career has a strong international dimension, as he has worked across Europe and the USA, at HQ, regional and affiliate levels. He built and managed affiliates in Europe for both large and small organisations, and participated in payer negotiations in countries as diverse as Estonia and France. Currently head of lifecycle management and pricing excellence at Celgene, Steven is responsible for developing the company’s approach to managing mature products, and also for developing new pricing approaches to address challenges such as novel-novel combinations and indication-based pricing. Prior to joining Celgene, Steven worked for more than 10 years in life science consulting, most recently at IMS Consulting Group (now part of QuintilesIMS), where he was a Principal within the pricing and market access practice. A Canadian-British dual national, Steven holds an MBA from INSEAD in France, and a Bachelor of Commerce (marketing and international business) from UBC in Canada.